18 Nov

Amgen Rises by 2% as XBI’s Large-Cap Stocks Rally

WRITTEN BY Peter Neil

XBI’s large-cap stocks rally

The large-cap (large capitalization) stocks of the SPDR S&P Biotech ETF (XBI) rose by 1.5% on a collective effort. As of November 17, 2015, XBI has 12 large-cap stocks with a market capitalization of more than $10 billion.

Large-cap stocks account for ~13.1% of XBI’s portfolio. The breadth among XBI’s large-cap stocks remained positive, with 11 stocks giving positive returns, while only one stock ended up in the red.

Amgen Rises by 2% as XBI’s Large-Cap Stocks Rally

XBI’s large-cap stocks include Alkermes (ALKS), BioMarin Pharmaceuticals (BMRN), and Vertex Pharmaceuticals (VRTX), which gave returns of 1.5%, 2.7%, and 2.4%, respectively.

The above graph reflects the collective performance of XBI’s large-cap stocks in comparison with XBI and the SPDR S&P 500 ETF (SPY). Since the beginning of November 2015, XBI’s large-cap stocks have returned -1.5%, XBI has returned 3.3%, and SPY has returned -1.2%. Thus, XBI outperformed both its large-cap stocks and SPY.

Amgen to present Phase 3 IMLYGIC data

Amgen (AMGN) gained 2% on November 17, 2015. As per its press release, AMGN announced “that the Company will present eight IMLYGICTM (talimogene laherparepvec) abstracts, including data from the Phase 3 trial and new data from its Phase 1b combination trial with Merck’s anti-PD-1 therapy, at the 12th International Congress of the Society for Melanoma Research (SMR), to be held on Nov. 18-21 in San Francisco.”

AMGN closed at $157.60 and was trading above its 50- and 100-day moving averages. The stock also witnessed a rise in trading volumes, with ~36 million shares being traded compared to its five-day average trading volume of 3.1 million shares per day.

AMGN’s trailing-12-month price-to-earnings ratio stood at 18.80x. It has a book value of $37.05 per share. With its current price, AMGN is trading at a price-to-book value ratio (or PBV) of 4.25x. AMGN has a weight of ~1.2% in XBI’s portfolio.

Latest articles

An expanding vehicle population offers more opportunities for investors aftermarket in the specialty car equipment industry.

The semiconductor sector saw some mixed earnings in the third quarter, and Advanced Micro Devices (AMD) is worth a closer look.

Roku’s third-quarter earnings results beat Wall Street’s expectations but still caused the stock to drop 16%. Is its competition really a threat?

The slowdown in the world’s largest auto market, China, is affecting electric vehicle companies worldwide. And it's probably going to last.

Tyson Foods (TSN) reported lower-than-expected sales and earnings for the fourth quarter of fiscal 2019, yet the stock is in the green.

On November 12, the cannabis sector was in the red despite the broader US equity market trading in positive territory. Here's why.